Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China · Delayed Price · Currency is CNY 23.06
0.00 (0.00%)
Sep 4, 2026, 3:00 PM CST
SHA:600993 Revenue
Mayinglong Pharmaceutical Group had revenue of 999.38M CNY in the quarter ending June 30, 2026, with 1.99% growth. This brings the company's revenue in the last twelve months to 3.93B, up 4.80% year-over-year. In the year 2025, Mayinglong Pharmaceutical Group had annual revenue of 3.87B with 3.72% growth.
Revenue (ttm)
3.93B
Revenue Growth
+4.80%
P/S Ratio
2.53
Revenue / Employee
1.54M
Employees
2,544
Market Cap
9.94B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.87B | 138.58M | 3.72% |
| Dec 31, 2024 | 3.73B | 591.28M | 18.85% |
| Dec 31, 2023 | 3.14B | -395.63M | -11.20% |
| Dec 31, 2022 | 3.53B | 147.32M | 4.35% |
| Dec 31, 2021 | 3.39B | 593.47M | 21.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.